Drugs that contain Bepotastine Besilate

1. List of Bepreve drug patents

BEPREVE Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8877168 BAUSCH AND LOMB INC Aqueous liquid preparations and light-stabilized aqueous liquid preparations
Jul, 2023

(4 months from now)

US8784789 BAUSCH AND LOMB INC Aqueous liquid preparations and light-stabilized aqueous liquid preparations
Jan, 2025

(1 year, 9 months from now)

Market Authorisation Date: 08 September, 2009

Treatment: NA

Dosage: SOLUTION/DROPS;OPHTHALMIC

How can I launch a generic of BEPREVE before it's patent expiration?
More Information on Dosage

BEPREVE family patents

5

United States

3

Japan

1

Korea, Republic of

1

Australia

1

Austria

1

Spain

1

China

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic